You are here:
Peroxisome Proliferator Activated Receptors Alpha, Beta, and Gamma mRNA and protein expression in human fetal tissues
Citation:
ABBOTT, B. D., C. R. WOOD, A. WATKINS, K. DAS, AND C. S. Lau. Peroxisome Proliferator Activated Receptors Alpha, Beta, and Gamma mRNA and protein expression in human fetal tissues. PPAR research. Hindawi Publishing Corporation, New York, NY, 2010(ID 6909907):19 pages, (2010).
Impact/Purpose:
This paper represents the continuing efforts at ORD, in response to the call for assistance from OPPTS, to investigate the potential developmental toxicities of pertluoroalkyl acids (PFAA). Per11uorooctanoic acid (PFOA) is a compound which persists and is found ubiquitously in the environment, wildlife and humans. Studies in our laboratory using an in vitro transfected cell model showed that PFOA and other PFAA activate PPARa. PFOA is developmentally toxic in mice and affects growth, development and viability of offspring exposed during gestation. Our studies in PPARa null mice showed that that these effects are dependent on expression of PPARa in the fetus. This study examines expression of PPARa, r3, and y mRNA and protein in embryonic day 54-125 human fetal liver, heart, lung, kidney, stomach, intestine, adrenal, spleen, and thymus. Fetal PPAR mRNA expression was compared to that of adult samples. This study provides new information on expression of PPAR subtypes during human development and will be important in evaluating the potential for the developing human to respond to PPAR environmental agonists.
Description:
Peroxisome proliferator-activated receptors (PPARs) regulate lipid and glucose homeostasis, are targets of pharmaceuticals, and are also activated by environmental contaminants. Almost nothing is known about expression of PPARs during human fetal development. This study examines expression of PPARα, β, and γ mRNA and protein in human fetal tissues. With increasing fetal age, mRNA expression of PPARα and β increased in liver, but PPARβ decreased in heart and intestine, and PPARγ decreased in adrenal. Adult and fetal mean expression of PPARα, β, and γ mRNA did not differ in intestine, but expression was lower in fetal stomach and heart. PPARα and β mRNA in kidney and spleen, and PPARγ mRNA in lung and adrenal were lower in fetal versus adult. PPARγ in liver and PPARβ mRNA in thymus were higher in fetal versus adult. PPARα protein increased with fetal age in intestine and decreased in lung, kidney, and adrenal. PPARβ protein in adrenal and PPARγ in kidney decreased with fetal age. This study provides new information on expression of PPAR subtypes during human development and will be important in evaluating the potential for the developing human to respond to PPAR environmental or pharmaceutical agonists
